LOC105377703 |
|
uncharacterized LOC105377703
|
|
|
|
|
SYNDIG1 |
Q9H7V2
|
synapse differentiation inducing 1
|
|
0.30 |
1.000 |
0.038 |
NCKAP5 |
O14513
|
NCK associated protein 5
|
|
8.5E-06 |
1.000 |
0.077 |
ABHD14B |
Q96IU4
|
abhydrolase domain containing 14B
|
|
1.4E-04 |
0.931 |
0.077 |
PSG6 |
Q00889
|
pregnancy specific beta-1-glycoprotein 6
|
|
4.8E-22 |
0.890 |
0.077 |
KCNS1 |
Q96KK3
|
potassium voltage-gated channel modifier subfamily S member 1
|
Ion channel
|
0.11 |
0.890 |
0.115 |
NKPD1 |
Q17RQ9
|
NTPase KAP family P-loop domain containing 1
|
|
7.0E-07 |
0.890 |
0.115 |
R3HDML |
Q9H3Y0
|
R3H domain containing like
|
Immune response
|
1.9E-06 |
0.931 |
0.115 |
TEMPS |
|
Temple syndrome
|
|
|
0.780 |
0.154 |
SHC4 |
Q6S5L8
|
SHC adaptor protein 4
|
|
7.1E-11 |
0.805 |
0.154 |
MORC1 |
Q86VD1
|
MORC family CW-type zinc finger 1
|
|
5.9E-06 |
0.805 |
0.192 |
GET1 |
O00258
|
guided entry of tail-anchored proteins factor 1
|
|
8.7E-04 |
0.805 |
0.192 |
KSR2 |
Q6VAB6
|
kinase suppressor of ras 2
|
Kinase
|
1.00 |
0.743 |
0.231 |
ITIH3 |
Q06033
|
inter-alpha-trypsin inhibitor heavy chain 3
|
Enzyme modulator
|
1.5E-13 |
0.769 |
0.231 |
MEA1 |
Q16626
|
male-enhanced antigen 1
|
|
1.1E-05 |
0.839 |
0.231 |
SV2A |
Q7L0J3
|
synaptic vesicle glycoprotein 2A
|
Transporter
|
0.23 |
0.722 |
0.269 |
MDD1 |
|
Major depressive disorder
|
|
|
0.682 |
0.308 |
HTR1D |
P28221
|
5-hydroxytryptamine receptor 1D
|
G-protein coupled receptor
|
6.4E-04 |
0.716 |
0.308 |
RAPGEF6 |
Q8TEU7
|
Rap guanine nucleotide exchange factor 6
|
Enzyme modulator
|
1.00 |
0.821 |
0.308 |
BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
COPE |
O14579
|
COPI coat complex subunit epsilon
|
Transporter
|
0.69 |
0.686 |
0.385 |
SP100 |
P23497
|
SP100 nuclear antigen
|
|
2.8E-12 |
0.729 |
0.385 |
NRN1 |
Q9NPD7
|
neuritin 1
|
|
0.86 |
0.736 |
0.385 |
TCF20 |
Q9UGU0
|
transcription factor 20
|
Transcription factor
|
1.00 |
0.644 |
0.423 |
LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |